Factors and management techniques in odontogenic keratocysts: a systematic review.


Journal

European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857

Informations de publication

Date de publication:
15 May 2024
Historique:
received: 26 01 2024
accepted: 22 04 2024
medline: 16 5 2024
pubmed: 16 5 2024
entrez: 15 5 2024
Statut: epublish

Résumé

Odontogenic keratocysts exhibit frequent recurrence, distinctive histopathological traits, a tendency towards aggressive clinical behavior, and a potential linkage to the nevoid basal cell carcinoma syndrome. The aim of this systematic review is to compile insights concerning the control of this condition and assess the effectiveness of various treatment approaches in reducing the likelihood of recurrence. The following systematic review adhered to the PRISMA guidelines. The systematic revision was registered on PROSPERO and  structured around the questions related to the population, intervention, control, outcome and study design (PICOS). After conducting a search on the PubMed database, we initially identified 944 records. After using end-note software to remove duplicate entries, results totally with 462 distinct records. A thorough review of the titles and abstracts of these articles led to the selection of 50 papers for in-depth examination. Ultimately, following the application of our eligibility criteria, we incorporated 11 articles into our primary outcome analysis. Among the studies examined, the most common location for these lesions was found to be in the area of the mandibular ramus and the posterior region of the mandible. In cases where the exact location wasn't specified, the mandible emerged as the predominant site. When we considered the characteristics of these lesions in studies that mentioned locularity, most were described as unilocular in two studies, while in two other studies, the prevalence of multilocular lesions was observed. Risk factors associated with keratocyst recurrence include younger patient age, the presence of multilocular lesions, larger lesion size, and a longer anteroposterior dimension. Certain treatment methods have demonstrated a lack of relapses. These include the use of 5-fluorouracil, marsupialization, enucleation with peripheral ostectomy or resection, enucleation and curettage, as well as resection without creating continuity defects. However, it is important to note that further research is essential. Prospective studies and randomized trials are needed to collect more comprehensive evidence regarding the effectiveness of various treatment approaches and follow-up protocols for managing odontogenic keratocysts. Odontogenic keratocysts still enter into differential diagnoses with other lesions that affect the jaw bones such as ameloblastama and other tumor forms, furthermore it is not free from recurrence, therefore the therapeutic approach to the lesion aimed at its elimination can influence both the possible recurrence and complications, knowledge of the surgical methods that offer the most predictable and clinically relevant result for the management of follow-up and recurrences.

Identifiants

pubmed: 38750607
doi: 10.1186/s40001-024-01854-z
pii: 10.1186/s40001-024-01854-z
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

287

Informations de copyright

© 2024. The Author(s).

Références

Speight PM, Takata T. New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours. Virchows Arch 2018;472:331–9. https://doi.org/10.1007/s00428-017-2182-3
Dammer R, Niederdellmann H, Dammer P, Nuebler-Moritz M. Conservative or radical treatment of keratocysts: a retrospective review. Br J Oral Maxillofac Surg. 1997;35:46–8. https://doi.org/10.1016/s0266-4356(97)90009-7 .
doi: 10.1016/s0266-4356(97)90009-7 pubmed: 9043004
Ahlfors E, Larsson A, Sjögren S. The odontogenic keratocyst: a benign cystic tumor? J Oral Maxillofac Surg. 1984;42:10–9. https://doi.org/10.1016/0278-2391(84)90390-2 .
doi: 10.1016/0278-2391(84)90390-2 pubmed: 6199488
Stoelinga PJ. Long-term follow-up on keratocysts treated according to a defined protocol. Int J Oral Maxillofac Surg. 2001;30:14–25. https://doi.org/10.1054/ijom.2000.0027 .
doi: 10.1054/ijom.2000.0027 pubmed: 11289615
Barnes L. Pathology and genetics of head and neck tumours; IARC.2005;9.
Soluk-Tekkesin M, Wright JM. The World Health Organization classification of odontogenic lesions: a summary of the changes of the 2022 (5th) edition. Turk Patoloji Derg. 2022;38:168–84. https://doi.org/10.5146/tjpath.2022.01573 .
doi: 10.5146/tjpath.2022.01573 pubmed: 35578902 pmcid: 9999699
Brannon RB. The odontogenic keratocyst. A clinicopathologic study of 312 cases. Part I. Clinical features. Oral Surg Oral Med Oral Pathol. 1976;42:54–72. https://doi.org/10.1016/0030-4220(76)90031-1 .
doi: 10.1016/0030-4220(76)90031-1 pubmed: 1065842
Titinchi F. Protocol for management of odontogenic keratocysts considering recurrence according to treatment methods. J Korean Assoc Oral Maxillofac Surg. 2020;46:358–60. https://doi.org/10.5125/jkaoms.2020.46.5.358 .
doi: 10.5125/jkaoms.2020.46.5.358 pubmed: 33122462 pmcid: 7609937
Kolokythas A, Fernandes RP, Pazoki A, Ord RA. Odontogenic keratocyst: to decompress or not to decompress? A comparative study of decompression and enucleation versus resection/peripheral ostectomy. J Oral Maxillofac Surg. 2007;65:640–4. https://doi.org/10.1016/j.joms.2006.06.284 .
doi: 10.1016/j.joms.2006.06.284 pubmed: 17368357
Troiano G, Dioguardi M, Cocco A, Laino L, Cervino G, Cicciu M, Ciavarella D, Lo Muzio L. Conservative vs radical approach for the treatment of solid/multicystic ameloblastoma: a systematic review and meta-analysis of the last decade. Oral Health Prev Dent. 2017;15:421–6. https://doi.org/10.3290/j.ohpd.a38732 .
doi: 10.3290/j.ohpd.a38732 pubmed: 28748232
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-34. https://doi.org/10.1016/j.jclinepi.2009.06.006 .
doi: 10.1016/j.jclinepi.2009.06.006 pubmed: 19631507
Maurette PE, Jorge J, de Moraes M. Conservative treatment protocol of odontogenic keratocyst: a preliminary study. J Oral Maxillofac Surg. 2006;64:379–83. https://doi.org/10.1016/j.joms.2005.11.007 .
doi: 10.1016/j.joms.2005.11.007 pubmed: 16487797
Nakamura N, Mitsuyasu T, Mitsuyasu Y, Taketomi T, Higuchi Y, Ohishi M. Marsupialization for odontogenic keratocysts: long-term follow-up analysis of the effects and changes in growth characteristics. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:543–53. https://doi.org/10.1067/moe.2002.128022 .
doi: 10.1067/moe.2002.128022 pubmed: 12424446
Bataineh AB, Al Qudah M. Treatment of mandibular odontogenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:42–7. https://doi.org/10.1016/s1079-2104(98)90148-2 .
doi: 10.1016/s1079-2104(98)90148-2 pubmed: 9690244
Leung YY, Lau SL, Tsoi KY, Ma HL, Ng CL. Results of the treatment of keratocystic odontogenic tumours using enucleation and treatment of the residual bony defect with carnoy’s solution. Int J Oral Maxillofac Surg. 2016;45:1154–8. https://doi.org/10.1016/j.ijom.2016.02.002 .
doi: 10.1016/j.ijom.2016.02.002 pubmed: 26922497
Berge TI, Helland SB, Sælen A, Øren M, Johannessen AC, Skartveit L, Grung B. Pattern of recurrence of nonsyndromic keratocystic odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122:10–6. https://doi.org/10.1016/j.oooo.2016.01.004 .
doi: 10.1016/j.oooo.2016.01.004 pubmed: 27039008
Pogrel MA, Jordan RC. Marsupialization as a definitive treatment for the odontogenic keratocyst. J Oral Maxillofac Surg. 2004;62:651–65. https://doi.org/10.1016/j.joms.2003.08.029 .
doi: 10.1016/j.joms.2003.08.029 pubmed: 15170272
Tabrizi R, Özkan BT, Dehgani A, Langner NJ. Marsupialization as a treatment option for the odontogenic keratocyst. J Craniofac Surg. 2012;23:e459-461. https://doi.org/10.1097/SCS.0b013e31825b3308 .
doi: 10.1097/SCS.0b013e31825b3308 pubmed: 22976707
Zecha JA, Mendes RA, Lindeboom VB, van der Waal I. Recurrence rate of keratocystic odontogenic tumor after conservative surgical treatment without adjunctive therapies-a 35 year single institution experience. Oral Oncol. 2010;46:740–2. https://doi.org/10.1016/j.oraloncology.2010.07.004 .
doi: 10.1016/j.oraloncology.2010.07.004 pubmed: 20797899
Moellmann HL, Parviz A, Goldmann-Kirn M, Rana M, Rana M. Comparison of five different treatment approaches of mandibular keratocystic odontogenic keratocyst (OKC): a retrospective recurrence analysis of clinical and radiographic parameters. J Maxillofac Oral Surg. 2023. https://doi.org/10.1007/s12663-023-01929-0 .
doi: 10.1007/s12663-023-01929-0 pubmed: 38312982 pmcid: 10830970
Caminiti MF, El-Rabbany M, Jeon J, Bradley G. 5-fluorouracil is associated with a decreased recurrence risk in odontogenic keratocyst management: a retrospective cohort study. J Oral Maxillofac Surg. 2021;79:814–21. https://doi.org/10.1016/j.joms.2020.07.215 .
doi: 10.1016/j.joms.2020.07.215 pubmed: 32866486
Marker P, Brøndum N, Clausen PP, Bastian HL. Treatment of large odontogenic keratocysts by decompression and later cystectomy: a long-term follow-up and a histologic study of 23 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;82:122–31. https://doi.org/10.1016/s1079-2104(96)80214-9 .
doi: 10.1016/s1079-2104(96)80214-9 pubmed: 8863300
August M, Faquin WC, Troulis MJ, Kaban LB. Dedifferentiation of odontogenic keratocyst epithelium after cyst decompression. J Oral Maxillofac Surg. 2003;61:678–83. https://doi.org/10.1053/joms.2003.50137 .
doi: 10.1053/joms.2003.50137 pubmed: 12796876
Brøndum N, Jensen VJ. Recurrence of keratocysts and decompression treatment. a long-term follow-up of forty-four cases. Oral Surg Oral Med Oral Pathol. 1991;72:265–9. https://doi.org/10.1016/0030-4220(91)90211-t .
doi: 10.1016/0030-4220(91)90211-t pubmed: 1717918
HP P. Om keratocyster (kolesten tomer) in the jaws. Tandlaegebladet. 1956;60:963–81.
Toller P. Origin and growth of cysts of the jaws. Ann R Coll Surg Engl. 1967;40:306–36.
pubmed: 6024922 pmcid: 2312107
Pindborg JJ, Hansen J. Studies on odontogenic cyst epithelium. 2. clinical and roentgenologic aspects of odontogenic keratocysts. Acta Pathol Microbiol Scand. 1963;58:283–94.
doi: 10.1111/j.1699-0463.1963.tb01572.x pubmed: 14044666
Rud J, Pindborg JJ. Odontogenic keratocysts: a follow-up study of 21 cases. J Oral Surg. 1969;27:323–30.
pubmed: 5253512
Panders AK, Haddlers HN. Solitary keratocysts of the jaws. J Oral Surg. 1969;27:931–8.
pubmed: 5260718
Scarfe WC, Toghyani S, Azevedo B. Imaging of benign odontogenic lesions. Radiol Clin North Am. 2018;56:45–62. https://doi.org/10.1016/j.rcl.2017.08.004 .
doi: 10.1016/j.rcl.2017.08.004 pubmed: 29157548
Eryilmaz T, Ozmen S, Findikcioglu K, Kandal S, Aral M. Odontogenic keratocyst: an unusual location and review of the literature. Ann Plast Surg. 2009;62:210–2. https://doi.org/10.1097/SAP.0b013e31817dad9c .
doi: 10.1097/SAP.0b013e31817dad9c pubmed: 19158536
Pitak-Arnnop P, Chaine A, Oprean N, Dhanuthai K, Bertrand JC, Bertolus C. Management of odontogenic keratocysts of the jaws: a 10 year experience with 120 consecutive lesions. J Craniomaxillofac Surg. 2010;38:358–64. https://doi.org/10.1016/j.jcms.2009.10.006 .
doi: 10.1016/j.jcms.2009.10.006 pubmed: 19897381
Kaczmarzyk T, Mojsa I, Stypulkowska J. A systematic review of the recurrence rate for keratocystic odontogenic tumour in relation to treatment modalities. Int J Oral Maxillofac Surg. 2012;41:756–67. https://doi.org/10.1016/j.ijom.2012.02.008 .
doi: 10.1016/j.ijom.2012.02.008 pubmed: 22445416
Dashow JE, McHugh JB, Braun TM, Edwards SP, Helman JI, Ward BB. Significantly decreased recurrence rates in keratocystic odontogenic tumor with simple enucleation and curettage using carnoy’s versus modified carnoy’s solution. J Oral Maxillofac Surg. 2015;73:2132–5. https://doi.org/10.1016/j.joms.2015.05.005 .
doi: 10.1016/j.joms.2015.05.005 pubmed: 26044601

Auteurs

Mario Dioguardi (M)

Department of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122, Foggia, Italy. mario.dioguardi@unifg.it.

Cristian Quarta (C)

Department of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122, Foggia, Italy.

Diego Sovereto (D)

Department of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122, Foggia, Italy.

Giorgia Apollonia Caloro (GA)

Unità Operativa Nefrologia e Dialisi, Presidio Ospedaliero Scorrano, ASL (Azienda Sanitaria Locale) Lecce, Via Giuseppina Delli Ponti, 73020, Scorrano, Italy.

Andrea Ballini (A)

Department of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122, Foggia, Italy.

Riccardo Aiuto (R)

Department of Biomedical, Surgical, and Dental Science, University of Milan, 20122, Milan, Italy.

Angelo Martella (A)

DataLab, Department of Engineering for Innovation, University of Salento, Lecce, Italy.

Lorenzo Lo Muzio (L)

Department of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122, Foggia, Italy.

Michele Di Cosola (M)

Department of Clinical and Experimental Medicine, University of Foggia, Via Rovelli 50, 71122, Foggia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH